Novanta Q1 Earnings Call Highlights

3 hours ago 4

MarketBeat

Tue, May 12, 2026 astatine 10:10 AM CDT 7 min read

Novanta logo

Key Points

Interested successful Novanta Inc.? Here are 5 stocks we similar better.
Novanta bushed expectations successful Q1 2026, with gross up 10% reported and 3% organically, bookings surging 37%, and adjusted EBITDA rising 14%. Management said momentum is improving and expects integrated maturation to scope the precocious azygous digits successful Q2.
Growth was broad-based crossed halfway businesses and AI-linked applications. Automation Enabling Technology gross grew 7% and Medical Solutions gross roseate 15%, portion AI information center-related applications accounted for astir 15% of gross and grew astir 20% twelvemonth implicit year.
The institution raised full-year gross guidance contempt borderline unit from tariffs and freight costs. Novanta present expects 2026 gross of $1.04 cardinal to $1.055 billion, portion reaffirming EBITDA and EPS guidance arsenic it works to retrieve margins done pricing actions and installation closures.

Novanta (NASDAQ:NOVT) reported stronger-than-expected first-quarter 2026 results, with absorption citing broad-based bookings growth, accelerating request successful automation and aesculapian markets, and rising vulnerability to artificial intelligence-related infrastructure applications.

Chair and Chief Executive Officer Matthijs Glastra said gross accrued 10% connected a reported ground and 3% organically successful the quarter, marking “a measurement up versus the anterior quarter.” Bookings roseate 37% twelvemonth implicit year, and the institution posted a book-to-bill ratio of 1.10. Glastra said each concern delivered double-digit bookings maturation and year-over-year gross growth.

→ Beyond NVIDIA: Picks-and-Shovels AI Plays with Strong Momentum

Adjusted EBITDA accrued 14%, portion adjusted EBITDA borderline expanded 70 ground points twelvemonth implicit year. Adjusted diluted net per stock roseate 9%. Operating currency travel accrued 63% twelvemonth implicit year, and currency travel conversion to nett income was supra 200% successful the quarter.

“Our momentum is building,” Glastra said. He added that Novanta expects integrated maturation to scope the precocious azygous digits successful the 2nd 4th and sees continued acceleration successful the backmost fractional of the year, “absent a deeper displacement successful the macro and geopolitical environment.”

Bookings and New Products Support Growth Outlook

→ 3 Ways to Target the Resources Powering AI and Data Centers

Chief Financial Officer Robert Buckley said bookings spot supports a increasing backlog and a affirmative outlook for 2026. New merchandise income accrued much than 50% twelvemonth implicit year, lifting the company’s vitality scale to 27% of sales. Company-wide plan wins roseate astir 30% from the anterior year.

Medical extremity markets accounted for 53% of full institution income successful the archetypal quarter, portion precocious concern markets represented 47%. Medical consumable income remained astir 15% of full institution sales, with Buckley pointing to spot from caller merchandise launches successful Advanced Surgery.

Read Entire Article